Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers
Clinical trial NCT06435507 · COMPLETED
Trial details
- NCT number
- NCT06435507
- Sponsor
- Innovative Molecules GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2024-01-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.